Netlist (NLST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Jul, 2026Executive summary
The 2026 Annual Meeting is scheduled for September 18, 2026, at UCI Research Park, Irvine, CA, with voting on director elections and auditor ratification.
Proxy materials are distributed via both Internet and mail, with voting available online, by phone, mail, or in person.
Only stockholders of record as of July 22, 2026, are eligible to vote.
Voting matters and shareholder proposals
Three directors are nominated for election to serve until the 2027 Annual Meeting.
Ratification of Macias Gini & O'Connell LLP as independent registered public accounting firm for fiscal year 2026 is proposed.
Board recommends voting “FOR” all director nominees and auditor ratification.
Shareholder proposals for the 2027 meeting must be submitted by April 7, 2027.
Board of directors and corporate governance
Board consists of three members, with two deemed independent under Nasdaq standards.
Audit Committee was reinstated in June 2025, with Jun Cho as its sole member and financial expert.
No nominating or compensation committees; the full Board handles these functions.
Board reviews director independence, oversees risk, and manages executive succession planning.
Code of Business Conduct and Ethics applies to all directors, officers, and employees.
Latest events from Netlist
- Five-year Samsung alliance brings $750M in license fees, $1.5B supply, and joint tech innovation.NLST
Investor update - Shareholders will vote on director elections and auditor ratification at the 2026 annual meeting.NLST
Proxy filing - Q2 2026 delivered triple-digit sales growth and major Samsung deals amid strong AI memory demand.NLST
Q2 2026 - Q1 revenue up 262% to $104.9M, with strong AI demand and legal wins driving profitability.NLST
Q1 2026 - Q4 revenue soared 121% year-over-year as AI demand and memory shortages drove sharp price gains.NLST
Q4 2025 - Q3 sales up 5% to $42.2M, net loss narrowed, but litigation and supply risks persist.NLST
Q3 2025 - Q3 sales up 140% to $40.2M, net loss narrows, and major patent awards boost liquidity.NLST
Q3 2024 - Q2 sales up 267% to $36.8M, $750M in legal wins, but losses and collection risks persist.NLST
Q2 2024 - Revenue surged 113% in 2024, but losses and litigation risks remain high.NLST
Q4 2024